Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the changes in clinical and imaging outcomes following arthroscopic treatment of chondral lesion(s) by Radiofrequency-Based debridement or Mechanical Debridement in subjects 18-50 years of age.


Clinical Trial Description

This is a non-inferiority, prospective, single blinded, randomized, single-center study design with enrollment of 82 randomized subjects (to assure 70 subjects complete the study). The sample size of 82 participants was calculated from a power analysis. The study was powered to detect at least a seven point change in KOOS pain score based on achieving 80% statistical power to detect a non-inferiority margin. Study duration will be until the last subject enrolled reaches 52 weeks post-operative. The 82 randomized subjects will be randomized at a 1:1 ratio into the Werewolf Coblation wand treatment group or mechanical debridement treatment group. Subjects will be blinded to their treatment assignment until they complete all study visits. Upon withdraw from the study, termination from the study, or new or recurrent symptoms requiring a subsequent arthroscopy, the blinded assignment will be revealed to the subject. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03678948
Study type Interventional
Source Ohio State University
Contact
Status Terminated
Phase N/A
Start date November 8, 2018
Completion date February 8, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04840147 - A Comparison of JointRep® and Microfracture in Repair of Cartilage Lesions on the Femoral Condyle or Trochlea, N/A
Recruiting NCT03588975 - A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee Phase 3
Completed NCT01076673 - Effect of Autologous Peripheral Blood Stem Cell Treatment on Articular Cartilage Regeneration Phase 2
Terminated NCT05082831 - Human ECM Implanted Within Microfracture Interstices & the Cartilage Defect in the Knee to Regenerate Hyaline Cartilage Phase 1
Withdrawn NCT05300490 - Prednisolone Urinary Excretion Kinetics
Recruiting NCT05924763 - The Clinical Outcome of BiCRI in the Treatment of Chondral and Osteochondral Lesions N/A
Completed NCT02118519 - Mesenchymal Stem Cells in Knee Cartilage Injuries Phase 2
Active, not recruiting NCT02524509 - the Safety and Efficacy Evaluation of Chondron Compared With Mircrofracture of Knee Phase 4
Completed NCT01576159 - Serum Cartilage Oligomeric Matrix Protein Levels After 12 Weeks of Different Exercises Phase 0
Completed NCT03101163 - Efficacy and Safety Study of Intra-Articular Injections of Autologous Peripheral Blood Stem Cells Following Subchondral Drilling Surgery for the Treatment of Articular Cartilage Injury in the Knee Phase 2